Christopher S. Kroon
Partner
Duane Morris LLP
100 High Street, Suite 2400
Boston, MA 02110-1724
USA
Phone: +1 857 488 4276
Fax: +1 857 401 3008
Email: CSKroon@duanemorris.com

Christopher S. Kroon practices in the area of intellectual property litigation and has experience in patent and trademark prosecution. Drawing from his education and his experience as a research scientist in the vascular surgery department at Boston Medical Center, Mr. Kroon has handled all aspects of litigation involving a wide range of complex technologies and products, including pharmaceuticals; orthopedic implants; allografts; recombinant proteins; fluorescent lighting; epidermal scanners; and semiconductors. Mr. Kroon also assists clients with technology licensing and related business transactions. He is registered to practice before the U.S. Patent and Trademark Office and has prosecuted patent and trademark applications relating to medical devices, including stents, catheters and other transvascular devices, as well as recombinant proteins and hormone detection kits.

Mr. Kroon also handles a wide range of transactional matters relating to intellectual property including infringement and validity opinions, patent licenses, confidentiality agreements and due diligence.

Admitted to practice in Massachusetts, he is a member of the Massachusetts and Boston Bar Associations, the American Bar Association and the American Intellectual Property Law Association. Mr. Kroon is a 2004 magna cum laude graduate of the Franklin Pierce Law Center, where he was an editor of the Franklin Pierce Law Review, and a summa cum laude graduate of the University of New Hampshire. Mr. Kroon also studied at Tsinghua University in Beijing, China.

Areas of Practice

• Intellectual Property and Litigation

Representative Matters

• Howmedica Osteonics and Stryker v. Wright Medical Technology, Inc., Case No. 11-cv-06499 (D.N.J.- S. Wigenton). Member of the trial team representing Wright Medical in a patent infringement litigation concerning an acetabular cup systems used during hip replacement surgery.
• Wright Medical Technology, Inc. v. OsteoImplant Technology, Inc., Case No. 04-cv-1167 (D.N.J.- M. Bumb). Patent infringement litigation with tens of millions at stake concerning modular hip replacement prostheses. Settled on terms the client found favorable.
• Howmedica Osteonics v. Wright Medical Technology, Inc., Case No. 00-cv-1167 (D.N.J.- S. Wigenton). Won summary judgment in the District of New Jersey in a patent infringement litigation concerning artificial knee implant technology with tens of millions at stake.
• Wright Medical Technologies Inc. v. LifeCell Corp., (2007 AAA Arbitration). Represented Wright Medical in a five-day arbitration concerning distribution rights to LifeCell's GraftJacket® xenograft tissue product.
• Abbott Laboratories v. Sandoz Inc., 10-538 (D.Del.- S. Robinson). Representing Sandoz in litigation regarding NIASPAN®, the active ingredient of which is niacin.
• King Pharmaceuticals, Inc. et al. v. Actavis Inc., et al., Case No. 07-05041 (D.N.J. - G. Brown). Represented Actavis in ANDA litigation regarding AVINZA®, the active ingredient of which is morphine sulfate.
• Wyeth v. Apotex Inc. et al., Case No. 08-CIV-22308 (S.D.Fla. - F. Moreno). Represented Apotex in ANDA litigation regarding EFFEXOR® XR (venlafaxine hydrochloride). Settled after two phases of trial were completed.
• Sepracor v. Wockhardt, Case No. 09-CV-1302 (D.N.J. - D.Cavanaugh). Represented Wockhardt in ANDA litigation regarding LUNESTA®, the active ingredient of which is eszopiclone. Settled prior to trial on terms the client found favorable.
• Pfizer, Inc. v. Wockhardt, Case No. 12-CV-817 (D.Del.- S. Robinson). Representing Wockhardt in ANDA litigation regarding PRISTIQ®, the active ingredient of which is desvenlafaxine.
• Teva v. Watson, Case No. 10-CV-5078 (D.N.J. — C.Cecchi). Represented Watson Pharmaceuticals, Inc. in Hatch-Waxman Litigation against Teva Pharmaceutical Industries Ltd. concerning the Parkinson's disease drug AZILECT®, the active ingredient of which is rasagiline. The matter was settled during trial.
• Currently part of a team of lawyers representing a Fortune 100 pharmaceutical company in a multibillion-dollar patent and antitrust litigation arising out of technology relating to the pharmaceutical application of recombinant proteins.
• Part of a defense team for one of the largest manufacturers and distributors of lighting products in the United States. Representation involves several matters dealing with both design and utility patents concerning fluorescent and halogen light bulbs.
• Helped obtain a very favorable claim interpretation with respect to a patent asserted in one of client's key technology fields.
• Successfully opposed summary judgment on behalf of a small independent inventor against a Fortune 200 pharmaceutical company in a landmark decision relating to correction of patent inventorship.

Professional Activities

• American Bar Association
• Massachusetts State Bar Association
• Boston Bar Association
• American Intellectual Property Bar Association

Admissions

• Massachusetts
• U.S. Patent and Trademark Office
• U.S. District Court for the District of Massachusetts
• U.S. Court of Appeals for the First Circuit

Education

• Franklin Pierce Law Center, J.D., magna cum laude, 2004
  Editor, Franklin Pierce Law Review
• University of New Hampshire, B.S., summa cum laude, 1999

Experience

• Duane Morris LLP
  - Partner, 2013-present
  - Associate, 2005-2012
• Testa, Hurwitz & Thibeault LLP
  - Associate, 2004-2005
  - Summer Associate, 2003
• Boston Medical Center
  - Scientist, Vascular Surgery Department, 1999-2001
• University of New Hampshire
  - Cancer Research Assistant, 1998-1999

Selected Publications

• "U.S. Supreme Court Restores Generic Pharma's Ability to Challenge Orange Book Use Code Information," Duane Morris Alert, April 19, 2012
• "New Terrain," a legal analysis of the impact of the Supreme Court's decision in eBay Inc., et al. v. MercExchange LLC, 8-K Magazine, Fall 2006
• "Trade Secrets: A Concealed Weapon?" Spirit Airline's Skylights Magazine, January/February 2007